|
| Press Releases |
|
 |
|
| Thursday, June 26, 2025 |
|
|
IBI Announces 23-Fold Surge in Net Profit for FY2025 |
| IBI Group Holdings Limited ('IBI' or the 'Company', together with its subsidiaries, the 'Group'; Stock Code: 1547), a company focused on investments in the built environment, today announced its audited consolidated results for the year ended 31 March 2025 ('FY2025' or the 'year under review'). more info >> |
|
|
IBI公佈2025財年淨利潤大幅增長23倍 在充滿挑戰的環境中實現強勁業績 |
| IBI Group Holdings Limited（「IBI」或「公司」及其附屬公司統稱為「集團」；股份代號：1547）為一家專注於建築環境方面投資的公司，今日公佈其截至2025年3月31日止年度（「2025財年」或「回顧年內」）之經審核綜合業績。 more info >> |
|
|
IBI公布2025财年净利润大幅增长23倍 在充满挑战的环境中实现强劲业绩 |
| IBI Group Holdings Limited（“IBI”或“公司”及其附属公司统称为“集团”；股份代号：1547）为一家专注于建筑环境方面投资的公司，今日公布其截至2025年3月31日止年度（“2025财年”或“回顾年内”）之经审核综合业绩。 more info >> |
|
| Thursday, June 30, 2022 |
|
|
IBI Group公布二零二二财年全年业绩 面对市场挑战展现强韧抗逆力 |
| IBI Group Holdings Limited (「IBI」或「公司」，及其附属公司统称为「集团」；股份代号：1547）为一家专注于投资在建筑环境相关业务的上市控股公司，今日公布截至二零二二年三月三十一日止财政年度（「二零二二财年」）之业绩。 more info >> |
|
|
IBI Group公佈二零二二財年全年業績 面對市場挑戰展現強韌抗逆力 |
| IBI Group Holdings Limited (「IBI」或「公司」，及其附屬公司統稱為「集團」；股份代號：1547）為一家專注於投資在建築環境相關業務的上市控股公司，今日公佈截至二零二二年三月三十一日止財政年度（「二零二二財年」）之業績。 more info >> |
|
|
IBI Group Announces FY2022 Annual Results, Steadfast Resilience Albeit Market Challenges |
| IBI Group Holdings Limited ("IBI" or the "Company", together with its subsidiaries as the "Group"; Stock Code: 1547), a publicly listed company that holds investments in companies focusing on the Built Environment, today announced its business results for the financial year ended 31 March 2022 ("FY2022"). more info >> |
|
| Friday, May 27, 2022 |
|
|
IBI宣布收購歐洲戰略物業投資 |
| IBI Group Holdings Limited（「 IBI」或「 集團 」；股份代號： 1547） 為一家專注於建築環境的投資控股公司，旗下亦包括提供建築承包服務、分銷高科技和創新建築產品以及空氣質量監測產品的子公司。 more info >> |
|
|
IBI Announces Acquisition of Strategic Property Investment in Europe |
| IBI Group Holdings Limited ("IBI" or the "Group"; Stock Code: 1547), an investment holding company which specialises in the built environment including subsidiaries providing contracting services more info >> |
|
| Thursday, June 24, 2021 |
|
|
IBI Group實現非凡業績 年內溢利上升151.5% |
| IBI Group Holdings Limited (「IBI」或「公司」，及其附屬公司統稱為「集團」；股份代號：1547）為一家專注於投資在建築環境相關業務的上市控股公司，今日公佈截至二零二一年三月三十一日止年度（「二零二一財年」）之全年業績，即使Covid-19疫情對全球經濟造成破壞性的影響，集團仍實現非凡業績。 more info >> |
|
|
IBI Group Delivers Exceptional Results with Net Profit Surging 151.5% |
| IBI Group Holdings Limited ("IBI" or the "Company", together with its subsidiaries as the "Group"; Stock Code: 1547), a publicly listed company that holds investments in companies focusing on the Built Environment, today announced its business results for the financial year ended 31 March 2021 ("FY2021"), nothing short of remarkable in light of the devastating impact to the global economy caused by the COVID-19 pandemic. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 23:30: JST
|
|
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 22:30 HKT/SGT
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 22, 2026 19:05 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 17:46 HKT/SGT
|
|
|
天辰生物通過聆訊：深耕過敏與自身免疫領域 臨床療效全面領先
May 22, 2026 16:32 HKT/SGT
|
|
|
天辰生物通过聆讯：深耕过敏与自身免疫领域 临床疗效全面领先
May 22, 2026 16:32 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 11:05: JST
|
|
|
雲頂新耀獲主要股東康橋資本增持 全球化佈局有望持續受益
May 22, 2026 10:59 HKT/SGT
|
|
|
GTJAI Won Two Awards at HR Asia 2026
May 22, 2026 10:49 HKT/SGT
|
|
|
國泰君安國際斬獲HR Asia 2026年度兩項大獎
May 22, 2026 10:49 HKT/SGT
|
|
|
国泰君安国际斩获HR Asia 2026年度两项大奖
May 22, 2026 10:49 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 10:05 HKT/SGT
|
|
|
云顶新耀获主要股东康桥资本增持 全球化布局有望持续受益
May 22, 2026 10:05 HKT/SGT
|
|
|
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 22, 2026 0:23 JST
|
|
|
Honda to Begin Sales of Super-ONE Compact EV
May 22, 2026 0:16 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
